erratum · 2004
Erratum: CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
21 citationsDOI: https://doi.org/10.1038/nm0604-649cOpen accessPDF reported by metadata
Article
Article detail, metadata, authors, and available full-text links.
Paper reader
Loading paper...